ARTICLE
23 November 2020

New Platform In Connection With Pharmaceutical Patents

O
OLIVARES

Contributor

Our mission is to provide innovative solutions and highly specialized legal advice for clients facing the most complicated legal and business challenges in Mexico. OLIVARES is continuously at the forefront of new practice areas concerning copyright, litigation, regulatory, anti-counterfeiting, plant varieties, domain names, digital rights, and internet-related matters, and the firm has been responsible for precedent-setting decisions in patents, copyrights, and trademarks. Our firm is committed to developing the strongest group of legal professionals to manage the level of complexity and interdisciplinary orientation that clients require. During the first decade of the 21st century, the team successfully led efforts to reshape IP laws and change regulatory authorizations procedures in Mexico, not only through thought leadership and lobbying efforts, but the firm has also won several landmark and precedent-setting cases at the Mexican Federal and Supreme Courts levels, including in constitutional matters.
On November 13, the Ministry of Economy and the Ministry of Health in conjunction with the Mexican Patent and Trademark Office (IMPI) and the regulatory authority (COFEPRIS), announced...
Mexico Intellectual Property

On November 13, the Ministry of Economy and the Ministry of Health in conjunction with the Mexican Patent and Trademark Office (IMPI) and the regulatory authority (COFEPRIS), announced a new platform for the generation of a greater number of generics in the country.

The platform mainly consists of the following databases for drug patents:

  • Patents of drugs according to the generic name, non-proprietary name.
  • Drug patents whose validity is soon to expire,
  • Responses to intergovernmental consultations between IMPI and COFEPRIS in accordance with the patent linkage system (see newsletter https://bit.ly/32SMhlL).

The transparency, access and ease of information is positive. We will shortly be giving more details on the general operation of this new platform and its implications on the linking system.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More